Detection of BCR/ABL Translocation in Bone Marrow Derived Mesenchymal Stem Cells in Egyptian CML Patients
Author(s) -
Taghrid Gaafar,
Inas Raafat,
Azza A. Aly,
Nagwa Mohamed,
Reem Jan Farid,
Nevine E. Saad,
Rabab El Hawary,
Naglaa Mostafaa,
Mirhan Mohamed Ahmed
Publication year - 2015
Publication title -
open access macedonian journal of medical sciences
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.288
H-Index - 17
ISSN - 1857-9655
DOI - 10.3889/oamjms.2015.040
Subject(s) - mesenchymal stem cell , medicine , stem cell , bone marrow , cancer research , haematopoiesis , chromosomal translocation , myeloid leukemia , philadelphia chromosome , immunology , pathology , biology , microbiology and biotechnology , gene , genetics
Chronic myeloid leukemia (CML) is a clonal myeloproliferative disorder of hematopoietic stem cells. It is characterized at the cytogenetic level by Philadelphia (ph) chromosome and at the molecular level by the BCR/ABL gene rearrangement. Bone marrow derived mesenchymal stem cells (MSCs) are pluripotent stem cells that can differentiate into several mesenchymal tissues.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom